These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 9112495
1. Long-term followup of a bladder carcinoma cohort: questionable value of radical radiotherapy. Holmäng S, Hedelin H, Borghede G, Johansson SL. J Urol; 1997 May; 157(5):1642-6. PubMed ID: 9112495 [Abstract] [Full Text] [Related]
2. Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. Holmäng S, Hedelin H, Anderström C, Johansson SL. J Urol; 1997 Aug; 158(2):389-92. PubMed ID: 9224309 [Abstract] [Full Text] [Related]
3. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience. Serretta V, Lo Greco G, Pavone C, Pavone-Macaluso M. J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829 [Abstract] [Full Text] [Related]
4. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK. Urol Oncol; 2007 Apr; 25(4):303-9. PubMed ID: 17628296 [Abstract] [Full Text] [Related]
5. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Blank LE, Koedooder K, van Os R, van de Kar M, van der Veen JH, Koning CC. Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):454-8. PubMed ID: 17560734 [Abstract] [Full Text] [Related]
6. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. Holmäng S, Borghede G. J Urol; 1996 Jan 01; 155(1):100-2. PubMed ID: 7490801 [Abstract] [Full Text] [Related]
7. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
8. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S. Scand J Urol Nephrol; 2002 May 01; 36(5):339-43. PubMed ID: 12487737 [Abstract] [Full Text] [Related]
10. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Piet AH, Hulshof MC, Pieters BR, Pos FJ, de Reijke TM, Koning CC. Strahlenther Onkol; 2008 Jun 01; 184(6):313-8. PubMed ID: 18535807 [Abstract] [Full Text] [Related]
11. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Fokdal L, Høyer M, von der Maase H. Acta Oncol; 2004 Jun 01; 43(8):749-57. PubMed ID: 15764221 [Abstract] [Full Text] [Related]
12. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications. Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S. J Urol; 2002 May 01; 167(5):2007-11. PubMed ID: 11956428 [Abstract] [Full Text] [Related]
13. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin. Volkmer BG, Gschwend JE, Maier SH, Seidl-Schlick EM, Bach D, Romics I. J Urol; 2003 Mar 01; 169(3):931-4; discussion 934-5. PubMed ID: 12576815 [Abstract] [Full Text] [Related]
14. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y. Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495 [Abstract] [Full Text] [Related]
15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M. Ann Acad Med Stetin; 2000 Apr 01; 46():217-29. PubMed ID: 11712306 [Abstract] [Full Text] [Related]
16. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder. Poortmans PM, Richaud P, Collette L, Ho Goey S, Pierart M, Van Der Hulst M, Bolla M, EORTC Radiation Oncology Group. Acta Oncol; 2008 Apr 01; 47(5):937-40. PubMed ID: 18568488 [Abstract] [Full Text] [Related]
17. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
18. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. Itano NB, Blute ML, Spotts B, Zincke H. J Urol; 2000 Aug 01; 164(2):322-5. PubMed ID: 10893575 [Abstract] [Full Text] [Related]
19. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival]. Chauvet B, Félix-Faure C, Davin JL, Choquenet C, Alfonsi M, Reboul F. Cancer Radiother; 1998 Apr 01; 2 Suppl 1():85s-91s. PubMed ID: 9749086 [Abstract] [Full Text] [Related]